Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
General Radiation Oncology
Do you include a dural CTV margin for intact brain metastases touching the dura when treating with SRS or fSRT?
Related Questions
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How do you manage intradural - extramedullary metastases of the spinal cord from non-CNS malignancies?
Can patients receive adjuvant radiation therapy after keloid excision without primary closure, or would radiation impede healing by secondary intention?
Would you recommend adjuvant neck radiation for metastatic chordoma to cervical lymph node, s/p neck dissection, with 1/10 positive nodes and no residual on post op imaging?
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
Are you offering Lutathera for multiple recurrent meningiomas?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
When do you prefer to use bolus for treating superficial tumors adjacent to or involving the skin surface, especially for complex surface anatomy in the pelvis, head/neck, and extremity regions?
Do you ever consider a third course of CNS radiation to the same area for an in-field recurrence?
Are there any precautions you would take when radiating the pelvis in an obese patient with recent extensive ventral hernia repair to minimize dehiscence risk?
